BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14977989)

  • 21. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
    Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review.
    Schetters TP; Moubri K; Cooke BM
    J S Afr Vet Assoc; 2009 Jun; 80(2):75-8. PubMed ID: 19831266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological survey of Babesia gibsoni infection in dogs in Japan by enzyme-linked immunosorbent assay using B. gibsoni thrombospondin-related adhesive protein antigen.
    Konishi K; Sakata Y; Miyazaki N; Jia H; Goo YK; Xuan X; Inokuma H
    Vet Parasitol; 2008 Aug; 155(3-4):204-8. PubMed ID: 18565675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous in vitro culture of erythrocytic stages of Babesia gibsoni and virulence of the cultivated parasite.
    Sunaga F; Namikawa K; Kanno Y
    J Vet Med Sci; 2002 Jul; 64(7):571-5. PubMed ID: 12185309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the culture-derived soluble Babesia canis canis antigens derived from the Polish strains of the parasites.
    Adaszek L; Puchalski A; Dec M; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):399-403. PubMed ID: 23242220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a practical immunochromatographic test with recombinant P50 for the diagnosis of Babesia gibsoni infection in dogs.
    Verdida RA; Xuan X; Fukumoto S; Huang X; Zhou J; Igarashi I; Claveria FG; Nagasawa H
    Parasitology; 2005 Dec; 131(Pt 6):769-74. PubMed ID: 16336730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Babesia gibsoni: Serodiagnosis of infection in dogs by an enzyme-linked immunosorbent assay with recombinant BgTRAP.
    Goo YK; Jia H; Aboge GO; Terkawi MA; Kuriki K; Nakamura C; Kumagai A; Zhou J; Lee EG; Nishikawa Y; Igarashi I; Fujisaki K; Xuan X
    Exp Parasitol; 2008 Apr; 118(4):555-60. PubMed ID: 18155197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Babesia gibsoni ribosomal phosphoprotein P0 induces cross-protective immunity against B. microti infection in mice.
    Terkawi MA; Jia H; Zhou J; Lee EG; Igarashi I; Fujisaki K; Nishikawa Y; Xuan X
    Vaccine; 2007 Mar; 25(11):2027-35. PubMed ID: 17229504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of macrophages on the erythrocyte oxidative damage and the pathogenesis of anemia in Babesia gibsoni-infected dogs with low parasitemia.
    Otsuka Y; Yamasaki M; Yamato O; Maede Y
    J Vet Med Sci; 2002 Mar; 64(3):221-6. PubMed ID: 11999441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs.
    Cao S; Mousa AA; Aboge GO; Kamyingkird K; Zhou M; Moumouni PF; Terkawi MA; Masatani T; Nishikawa Y; Suzuki H; Fukumoto S; Xuan X
    Acta Parasitol; 2013 Dec; 58(4):619-23. PubMed ID: 24338330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Babesia gibsoni: An apical membrane antigen-1 homologue and its antibody response in the infected dogs.
    Zhou J; Yang J; Zhang G; Nishikawa Y; Fujisaki K; Xuan X
    Exp Parasitol; 2006 Dec; 114(4):329-33. PubMed ID: 16777097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Babesia gibsoni: identification of an immunodominant, interspersed repeat antigen.
    Jia H; Terkawi MA; Aboge GO; Goo YK; Zhou J; Lee EG; Nishikawa Y; Igarashi I; Fujisaki K; Xuan X
    Exp Parasitol; 2008 Jan; 118(1):146-9. PubMed ID: 17870070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
    Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level expression of truncated surface antigen P50 of Babesia gibsoni in insect cells by baculovirus and evaluation of its immunogenicity and antigenicity.
    Fukumoto S; Xuan X; Kadota K; Igarashi I; Sugimoto C; Fujisaki K; Nagasawa H; Mikami T; Suzuki H
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):596-601. PubMed ID: 12853391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and evaluation of serodiagnostic assays with recombinant BgSA1 of Babesia gibsoni.
    Mandal M; Banerjee PS; Kumar S; Garg R; Ram H; Kundu K; Raina OK
    Vet Parasitol; 2014 Oct; 205(3-4):483-9. PubMed ID: 25241636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens.
    Schetters TH; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1995 Apr; 17(4):215-8. PubMed ID: 7542765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressive effect of culture supernatant of erythrocytes and serum from dogs infected with Babesia gibsoni on the morphological maturation of canine reticulocytes in vitro.
    Hossain MA; Yamato O; Kim G; Yamasaki M; Maede Y
    J Vet Sci; 2007 Jun; 8(2):169-74. PubMed ID: 17519571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electron microscopic study of canine Babesia gibsoni infection.
    Radi ZA; Styer EL; Frazier KS
    J Vet Diagn Invest; 2004 May; 16(3):229-33. PubMed ID: 15152839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of dogs against Babesia canis infection.
    Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Goovaerts D
    Vet Parasitol; 1997 Dec; 73(1-2):35-41. PubMed ID: 9477490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Babesia divergens apical membrane antigen-1 (BdAMA-1): A poorly polymorphic protein that induces a weak and late immune response.
    Moreau E; Bonsergent C; Al Dybiat I; Gonzalez LM; Lobo CA; Montero E; Malandrin L
    Exp Parasitol; 2015 Aug; 155():40-5. PubMed ID: 25956948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.